Albert D. Dyrness - 11 Jul 2025 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Director
Signature
/s/ Albert D. Dyrness
Issuer symbol
SONN
Transactions as of
11 Jul 2025
Transactions value $
$0
Form type
4
Filing time
15 Jul 2025, 19:35:24 UTC
Previous filing
05 Dec 2024
Next filing
03 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dyrness Albert D. Director 100 OVERLOOK CENTER,, SUITE 102, PRINCETON, /s/ Albert D. Dyrness 15 Jul 2025 0001664801

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Award +4,000 +7.45% 4,537 11 Jul 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 11, 2025, the Reporting Person was granted 4,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on the earlier of (i) January 8, 2026, or (ii) the date of a "Change in Control" (as defined under the Issuer's 2020 Omnibus Equity Incentive Plan).
F2 Includes unvested restricted stock units.
F3 All amounts reflect the Issuer's 1:22 reverse stock split effective as of August 31, 2023 and 1:8 reverse stock split effective as of September 30, 2024.